Conceptus Falls 20% On Profit Prediction

July 9, 2010 · Filed Under Contraceptives · Comment 

Conceptus, Inc., (NASDAQ: CPTS) fell $3.13 (more than 20%) to $12.66 after the medical device company reported 2Q profits more than 10% lower than expected. The company expects annual profits may be down as much as 13% by the year’s end.

Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications. It offers Essure, a permanent birth control system for women.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed